AGP Picks
View all

Middle East Tech Today
Provided by AGP

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 28, 2026

Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development
May 28, 2026

Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development

Indeterminate GlobeNewswire
Global Mofy Enters into Cooperation with Amazon Web Services (AWS) and Advances AIGC Computing Infrastructure Deployment
May 28, 2026

Global Mofy Enters into Cooperation with Amazon Web Services (AWS) and Advances AIGC Computing Infrastructure Deployment

Indeterminate GlobeNewswire
WRAP Unveils Plans for Drone-Based Non-Lethal Response Payloads Incorporating Directional Light, Laser Dazzler, and Sensory Deterrence Technologies
May 28, 2026

WRAP Unveils Plans for Drone-Based Non-Lethal Response Payloads Incorporating Directional Light, Laser Dazzler, and Sensory Deterrence Technologies

Indeterminate GlobeNewswire
Cycurion Executes Seamless Chief Financial Officer Transition with Appointment of Ana Garcia
May 28, 2026

Cycurion Executes Seamless Chief Financial Officer Transition with Appointment of Ana Garcia

Indeterminate GlobeNewswire
Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
May 28, 2026

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation

Indeterminate GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
May 28, 2026

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum

Indeterminate GlobeNewswire
Aduro Clean Technologies to Participate in Industry and Investor Conferences in June 2026
May 28, 2026

Aduro Clean Technologies to Participate in Industry and Investor Conferences in June 2026

Indeterminate GlobeNewswire
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
May 28, 2026

FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY

Indeterminate GlobeNewswire
Quantum X Labs Launches 50+ Physical Qubits Neutral-Atom Quantum Computer, Targets Thousands Qubit Milestone by End of H1 2027
May 28, 2026

Quantum X Labs Launches 50+ Physical Qubits Neutral-Atom Quantum Computer, Targets Thousands Qubit Milestone by End of H1 2027

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
GoldHaven Expands District-Scale Airborne Survey at Magno to 2,237 Line-Kilometres to Advance 2026 Drill Targeting
May 28, 2026

GoldHaven Expands District-Scale Airborne Survey at Magno to 2,237 Line-Kilometres to Advance 2026 Drill Targeting

Indeterminate GlobeNewswire
Other World Computing to Showcase the Future of Creative Workflows at Cine Gear Expo LA
May 28, 2026

Other World Computing to Showcase the Future of Creative Workflows at Cine Gear Expo LA

Indeterminate GlobeNewswire
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
May 28, 2026

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Forge Nano and Group14 Advance U.S.-Made High-Performance Battery Cells with U.S. Material Supply Chain
May 28, 2026

Forge Nano and Group14 Advance U.S.-Made High-Performance Battery Cells with U.S. Material Supply Chain

Indeterminate GlobeNewswire
NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung
May 28, 2026

NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung

Indeterminate GlobeNewswire
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
May 28, 2026

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

Indeterminate GlobeNewswire
Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026
May 28, 2026

Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026

Indeterminate GlobeNewswire
Penetrating a $94.2 B Market: Braiin Launches AI-Native Living Infrastructure Platform in New Zealand, Targeting the Global PropTech Residential Lifecycle Services Market
May 28, 2026

Penetrating a $94.2 B Market: Braiin Launches AI-Native Living Infrastructure Platform in New Zealand, Targeting the Global PropTech Residential Lifecycle Services Market

Indeterminate GlobeNewswire
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

Indeterminate GlobeNewswire
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
May 28, 2026

RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.